# Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden

> clinical trial · VERIFIED · 2026-07-22

Status: NOT_YET_RECRUITING · Sponsor: AIO-Studien-gGmbH · Condition: Non-small Cell Lung Cancer Metastatic

- Company: AIO-Studien-gGmbH
- Sector: Non-small Cell Lung Cancer Metastatic
- Primary source: https://clinicaltrials.gov/study/NCT07715396

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.